Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nasdaq  >  Exelixis, Inc.    EXEL

EXELIXIS, INC.

(EXEL)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Exelixis, Inc. : annual earnings release

share with twitter share with LinkedIn share with facebook
share via e-mail
02/21/2020 | 09:15am EDT

The company will report its earnings for FY 2019 on 02/26/2020. Generally, the company reports earnings better than estimates. In recent months, the 12 analysts from Standard & Poor's consensus have revised their EPS estimates downward.


© MarketScreener.com 2020
share with twitter share with LinkedIn share with facebook
share via e-mail
Latest news on EXELIXIS, INC.
03/25EXELIXIS : Announces Partner Takeda Receives Approval in Japan for CABOMETYX® (c..
BU
03/02EXELIXIS : Announces George A. Scangos, Ph.D. to Retire From Its Board of Direct..
BU
02/26EXELIXIS : Announces Webcasts of Investor Conference Presentations in March
BU
02/25EXELIXIS : 4Q Earnings Snapshot
AQ
02/25EXELIXIS, INC. : Results of Operations and Financial Condition, Financial Statem..
AQ
02/25EXELIXIS : Management's Discussion and Analysis of Financial Condition and Resul..
AQ
02/25EXELIXIS : Announces First 100 Patients Enrolled in Phase 3 COSMIC-311 Pivotal T..
BU
02/25EXELIXIS : Announces Fourth Quarter and Full Year 2019 Financial Results and Pro..
BU
02/21EXELIXIS, INC. : annual earnings release
02/20EXELIXIS, INC. : Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year..
AQ
More news
Financials (USD)
Sales 2020 878 M
EBIT 2020 160 M
Net income 2020 141 M
Finance 2020 1 459 M
Yield 2020 -
P/E ratio 2020 40,7x
P/E ratio 2021 19,7x
EV / Sales2020 4,33x
EV / Sales2021 3,14x
Capitalization 5 262 M
Chart EXELIXIS, INC.
Duration : Period :
Exelixis, Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends EXELIXIS, INC.
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 16
Average target price 24,10  $
Last Close Price 17,23  $
Spread / Highest target 103%
Spread / Average Target 39,9%
Spread / Lowest Target 10,3%
EPS Revisions
Managers
NameTitle
Michael M. Morrissey President, Chief Executive Officer & Director
Stelios B. Papadopoulos Chairman
Christopher J. Senner Chief Financial & Accounting Officer, Executive VP
Gisela M. Schwab Chief Medical Officer & President-Medical Affairs
Peter Lamb Chief Scientific Officer & EVP-Scientific Strategy
Sector and Competitors
1st jan.Capitalization (M$)
EXELIXIS, INC.-2.21%5 262
GILEAD SCIENCES12.11%91 719
VERTEX PHARMACEUTICALS-0.78%56 324
REGENERON PHARMACEUTICALS19.72%48 934
WUXI APPTEC CO., LTD.1.28%21 638
GENMAB A/S-9.38%12 982